SAN FRANCISCO--(BUSINESS WIRE)--Fluxion Biosciences announced today that it has relocated its corporate headquarters to Oyster Point Business Park in South San Francisco, California. The company specializes in research tools for live cell image analysis in drug discovery. The new Fluxion facility is significantly larger than the company’s previous space and will accommodate research and development, operations, sales and marketing and customer service. The new headquarters space has been developed to meet Fluxion’s unique requirements for development of the company’s high throughput cell biology platforms, including state-of-the-art research labs, microfluidics clean rooms and advanced technology development labs.

Jeff Jensen, CEO of Fluxion, commented, “Our company has experienced rapid growth since its founding in 2005. Our space needs have grown dramatically with the successful launch of our BioFlux™ 200 System and the ongoing development of our next-generation platforms. As we continue to grow, our new facilities will help us better meet the needs of our current and future customers.”

About Fluxion Biosciences

Fluxion Biosciences develops cellular analysis tools for live cell image analysis for use in critical life science research and drug discovery application. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Fluxion systems meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, easy-to-use operating system for single-cell biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.